Evogene Reports Fourth Quarter and Full Year 2021 Financial Results

Go back to Evogene Reports Fourth Quarter and Full Year 2021 Financial Results

Evogene (EVGN) Misses Q3 EPS by 1c

March 10, 2022 7:07 AM EST

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $311 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

... More